16-week Open Randomized Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression: Pharmacogenomic and Biomarker Predictors of Response
Phase of Trial: Phase IV
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Fluoxetine (Primary) ; Lamotrigine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- Acronyms FLAME
- 15 Apr 2016 Status changed from active, no longer recruiting to recruiting.
- 15 Dec 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 15 Dec 2015 Study design changed from cross-over to parallel and minimum age of subjects included reduced from 85 to 65 years as per ClinicalTrials.gov record.